Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial Evaluating Continuous Infusion of Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

NCT01118676 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT01118676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial Evaluating Continuous Infusion of Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Lead sponsor
Institut Claudius Regaud
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2010
Completion date
April 30, 2015
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced non small cell lung cancer (nsclc)